Bank of Montreal Can lifted its holdings in shares of Teladoc Health Inc (NYSE:TDOC) by 41.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,565 shares of the health services provider’s stock after purchasing an additional 6,019 shares during the quarter. Bank of Montreal Can’s holdings in Teladoc Health were worth $1,776,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in TDOC. BlackRock Inc. boosted its holdings in Teladoc Health by 9.0% during the 2nd quarter. BlackRock Inc. now owns 5,318,850 shares of the health services provider’s stock valued at $308,759,000 after acquiring an additional 437,136 shares during the period. Bank of America Corp DE boosted its holdings in Teladoc Health by 82.8% during the 2nd quarter. Bank of America Corp DE now owns 1,883,185 shares of the health services provider’s stock valued at $109,318,000 after acquiring an additional 853,076 shares during the period. Zevenbergen Capital Investments LLC boosted its holdings in Teladoc Health by 3.9% during the 2nd quarter. Zevenbergen Capital Investments LLC now owns 1,629,170 shares of the health services provider’s stock valued at $94,574,000 after acquiring an additional 61,325 shares during the period. Gilder Gagnon Howe & Co. LLC boosted its holdings in Teladoc Health by 6.0% during the 2nd quarter. Gilder Gagnon Howe & Co. LLC now owns 1,477,276 shares of the health services provider’s stock valued at $85,756,000 after acquiring an additional 83,319 shares during the period. Finally, Northern Trust Corp boosted its holdings in Teladoc Health by 7.8% during the 2nd quarter. Northern Trust Corp now owns 799,539 shares of the health services provider’s stock valued at $46,414,000 after acquiring an additional 58,189 shares during the period.

Shares of TDOC opened at $62.49 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 8.99 and a quick ratio of 8.99. The stock has a market capitalization of $4.79 billion, a PE ratio of -37.87 and a beta of 0.96. Teladoc Health Inc has a 1 year low of $27.30 and a 1 year high of $89.05.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Thursday, November 1st. The health services provider reported ($0.34) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.36) by $0.02. The business had revenue of $111.00 million during the quarter, compared to analysts’ expectations of $109.94 million. Teladoc Health had a negative return on equity of 14.05% and a negative net margin of 31.32%. The business’s quarterly revenue was up 61.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.55) EPS. As a group, sell-side analysts expect that Teladoc Health Inc will post -1.47 EPS for the current year.

TDOC has been the subject of a number of research analyst reports. TheStreet cut Teladoc Health from a “c” rating to a “d+” rating in a report on Tuesday, October 9th. Craig Hallum raised their target price on Teladoc Health from $70.00 to $80.00 and gave the company a “buy” rating in a report on Monday, October 15th. SunTrust Banks raised their target price on Teladoc Health to $100.00 and gave the company a “buy” rating in a report on Monday, September 24th. Canaccord Genuity raised their target price on Teladoc Health from $70.00 to $86.00 and gave the company a “buy” rating in a report on Thursday, September 20th. Finally, Citigroup raised their target price on Teladoc Health to $80.00 and gave the company a “buy” rating in a report on Thursday, July 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $82.95.

In other news, insider Adam C. Vandervoort sold 5,550 shares of Teladoc Health stock in a transaction dated Monday, September 10th. The stock was sold at an average price of $77.67, for a total value of $431,068.50. Following the completion of the transaction, the insider now owns 2,934 shares in the company, valued at approximately $227,883.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jason N. Gorevic sold 25,000 shares of Teladoc Health stock in a transaction dated Thursday, August 16th. The shares were sold at an average price of $71.66, for a total value of $1,791,500.00. Following the completion of the transaction, the chief executive officer now owns 561,184 shares of the company’s stock, valued at approximately $40,214,445.44. The disclosure for this sale can be found here. Insiders sold a total of 235,930 shares of company stock valued at $17,033,927 in the last quarter. Company insiders own 3.95% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://theolympiareport.com/2018/11/11/teladoc-health-inc-tdoc-shares-bought-by-bank-of-montreal-can.html.

About Teladoc Health

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: Do Tariffs Work?

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.